Tag: contrast agent

guerbet

Guerbet announces US Food and Drug Administration approval of Elucirem

Guerbet announced that the US Food and Drug Administration (FDA), after priority review, has approved Elucirem (Gadopiclenol), a new macrocyclic gadolinium-based contrast agent (GBCA)...